nodes	percent_of_prediction	percent_of_DWPC	metapath
Quazepam—GABRR1—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0451	0.0451	CbGpPWpGaD
Quazepam—GABRR2—GABA receptor activation—KCNJ5—adrenal gland cancer	0.043	0.043	CbGpPWpGaD
Quazepam—GABRG3—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0354	0.0354	CbGpPWpGaD
Quazepam—GABRB1—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0349	0.0349	CbGpPWpGaD
Quazepam—GABRA5—GABA receptor activation—KCNJ5—adrenal gland cancer	0.029	0.029	CbGpPWpGaD
Quazepam—GABRA3—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0284	0.0284	CbGpPWpGaD
Quazepam—GABRA2—GABA receptor activation—KCNJ5—adrenal gland cancer	0.028	0.028	CbGpPWpGaD
Quazepam—GABRB3—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0278	0.0278	CbGpPWpGaD
Quazepam—GABRG2—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0273	0.0273	CbGpPWpGaD
Quazepam—GABRA1—GABA receptor activation—KCNJ5—adrenal gland cancer	0.0238	0.0238	CbGpPWpGaD
Quazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0207	0.0207	CbGpPWpGaD
Quazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0198	0.0198	CbGpPWpGaD
Quazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0163	0.0163	CbGpPWpGaD
Quazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.016	0.016	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0156	0.0156	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0149	0.0149	CbGpPWpGaD
Quazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0133	0.0133	CbGpPWpGaD
Quazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0131	0.0131	CbGpPWpGaD
Quazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0129	0.0129	CbGpPWpGaD
Quazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0128	0.0128	CbGpPWpGaD
Quazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0125	0.0125	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0122	0.0122	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0121	0.0121	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—KCNJ5—adrenal gland cancer	0.0119	0.0119	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—KCNJ5—adrenal gland cancer	0.0114	0.0114	CbGpPWpGaD
Quazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.011	0.011	CbGpPWpGaD
Quazepam—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0102	0.0102	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.01	0.01	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00983	0.00983	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00966	0.00966	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0096	0.0096	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00942	0.00942	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—KCNJ5—adrenal gland cancer	0.00938	0.00938	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—KCNJ5—adrenal gland cancer	0.00924	0.00924	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00824	0.00824	CbGpPWpGaD
Quazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00794	0.00794	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—KCNJ5—adrenal gland cancer	0.00767	0.00767	CbGpPWpGaD
Quazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00758	0.00758	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—KCNJ5—adrenal gland cancer	0.00753	0.00753	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—KCNJ5—adrenal gland cancer	0.0074	0.0074	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—KCNJ5—adrenal gland cancer	0.00735	0.00735	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—KCNJ5—adrenal gland cancer	0.00722	0.00722	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—KCNJ5—adrenal gland cancer	0.00631	0.00631	CbGpPWpGaD
Quazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00624	0.00624	CbGpPWpGaD
Quazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00615	0.00615	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00597	0.00597	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0057	0.0057	CbGpPWpGaD
Quazepam—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00559	0.00559	CbGpPWpGaD
Quazepam—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00557	0.00557	CbGpPWpGaD
Quazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0051	0.0051	CbGpPWpGaD
Quazepam—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0051	0.0051	CbGpPWpGaD
Quazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00501	0.00501	CbGpPWpGaD
Quazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00492	0.00492	CbGpPWpGaD
Quazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00489	0.00489	CbGpPWpGaD
Quazepam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00486	0.00486	CbGpPWpGaD
Quazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0048	0.0048	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00469	0.00469	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00462	0.00462	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—PRKACA—adrenal gland cancer	0.00458	0.00458	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—PRKACA—adrenal gland cancer	0.00436	0.00436	CbGpPWpGaD
Quazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00428	0.00428	CbGpPWpGaD
Quazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0042	0.0042	CbGpPWpGaD
Quazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00408	0.00408	CbGpPWpGaD
Quazepam—GABRB3—BDNF signaling pathway—CDC42—adrenal gland cancer	0.00406	0.00406	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00385	0.00385	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00384	0.00384	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00377	0.00377	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.0037	0.0037	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00368	0.00368	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00361	0.00361	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—PRKACA—adrenal gland cancer	0.00359	0.00359	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—PRKACA—adrenal gland cancer	0.00354	0.00354	CbGpPWpGaD
Quazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00336	0.00336	CbGpPWpGaD
Quazepam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00336	0.00336	CbGpPWpGaD
Quazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00331	0.00331	CbGpPWpGaD
Quazepam—GABRR1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00322	0.00322	CbGpPWpGaD
Quazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.0032	0.0032	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00316	0.00316	CbGpPWpGaD
Quazepam—GABRR2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00307	0.00307	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—PRKACA—adrenal gland cancer	0.00294	0.00294	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—PRKACA—adrenal gland cancer	0.00289	0.00289	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—PRKACA—adrenal gland cancer	0.00284	0.00284	CbGpPWpGaD
Quazepam—GABRB3—BDNF signaling pathway—BAD—adrenal gland cancer	0.00283	0.00283	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—PRKACA—adrenal gland cancer	0.00282	0.00282	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—PRKACA—adrenal gland cancer	0.00277	0.00277	CbGpPWpGaD
Quazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00275	0.00275	CbGpPWpGaD
Quazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.0027	0.0027	CbGpPWpGaD
Quazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00265	0.00265	CbGpPWpGaD
Quazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00264	0.00264	CbGpPWpGaD
Quazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00259	0.00259	CbGpPWpGaD
Quazepam—GABRG3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00253	0.00253	CbGpPWpGaD
Quazepam—GABRB1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00249	0.00249	CbGpPWpGaD
Quazepam—GABRR1—Neuronal System—BRAF—adrenal gland cancer	0.00247	0.00247	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00246	0.00246	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—PRKACA—adrenal gland cancer	0.00242	0.00242	CbGpPWpGaD
Quazepam—GABRR2—Neuronal System—BRAF—adrenal gland cancer	0.00235	0.00235	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00235	0.00235	CbGpPWpGaD
Quazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00232	0.00232	CbGpPWpGaD
Quazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00226	0.00226	CbGpPWpGaD
Quazepam—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00214	0.00214	CbGpPWpGaD
Quazepam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00211	0.00211	CbGpPWpGaD
Quazepam—GABRA5—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00207	0.00207	CbGpPWpGaD
Quazepam—GABRA3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00203	0.00203	CbGpPWpGaD
Quazepam—GABRA2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.002	0.002	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00199	0.00199	CbGpPWpGaD
Quazepam—GABRB3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00198	0.00198	CbGpPWpGaD
Quazepam—GABRR1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00196	0.00196	CbGpPWpGaD
Quazepam—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00195	0.00195	CbGpPWpGaD
Quazepam—GABRG2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00195	0.00195	CbGpPWpGaD
Quazepam—GABRG3—Neuronal System—BRAF—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00193	0.00193	CbGpPWpGaD
Quazepam—GABRB1—Neuronal System—BRAF—adrenal gland cancer	0.00191	0.00191	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.0019	0.0019	CbGpPWpGaD
Quazepam—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00188	0.00188	CbGpPWpGaD
Quazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00187	0.00187	CbGpPWpGaD
Quazepam—GABRB3—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Quazepam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00171	0.00171	CbGpPWpGaD
Quazepam—GABRA1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0017	0.0017	CbGpPWpGaD
Quazepam—GABRA5—Neuronal System—BRAF—adrenal gland cancer	0.00158	0.00158	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00158	0.00158	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00157	0.00157	CbGpPWpGaD
Quazepam—GABRA3—Neuronal System—BRAF—adrenal gland cancer	0.00156	0.00156	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00155	0.00155	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Quazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00154	0.00154	CbGpPWpGaD
Quazepam—GABRA2—Neuronal System—BRAF—adrenal gland cancer	0.00153	0.00153	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00153	0.00153	CbGpPWpGaD
Quazepam—GABRB3—Neuronal System—BRAF—adrenal gland cancer	0.00152	0.00152	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00152	0.00152	CbGpPWpGaD
Quazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00151	0.00151	CbGpPWpGaD
Quazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.0015	0.0015	CbGpPWpGaD
Quazepam—GABRG2—Neuronal System—BRAF—adrenal gland cancer	0.00149	0.00149	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00149	0.00149	CbGpPWpGaD
Quazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00139	0.00139	CbGpPWpGaD
Quazepam—GABRA1—Neuronal System—BRAF—adrenal gland cancer	0.0013	0.0013	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.0013	0.0013	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00128	0.00128	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Quazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00124	0.00124	CbGpPWpGaD
Quazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00123	0.00123	CbGpPWpGaD
Quazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00121	0.00121	CbGpPWpGaD
Quazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Quazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00118	0.00118	CbGpPWpGaD
Quazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00113	0.00113	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Quazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00103	0.00103	CbGpPWpGaD
Quazepam—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000999	0.000999	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000963	0.000963	CbGpPWpGaD
Quazepam—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000911	0.000911	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000893	0.000893	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000878	0.000878	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000814	0.000814	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000703	0.000703	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000641	0.000641	CbGpPWpGaD
Quazepam—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000601	0.000601	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000575	0.000575	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000575	0.000575	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000537	0.000537	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000525	0.000525	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000525	0.000525	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000429	0.000429	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000391	0.000391	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000384	0.000384	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00035	0.00035	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000346	0.000346	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000346	0.000346	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.000313	0.000313	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000306	0.000306	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000285	0.000285	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000279	0.000279	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000258	0.000258	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000254	0.000254	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000249	0.000249	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000231	0.000231	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000227	0.000227	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000188	0.000188	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—POMC—adrenal gland cancer	0.000171	0.000171	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000156	0.000156	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000153	0.000153	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.00015	0.00015	CbGpPWpGaD
Quazepam—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	0.000136	0.000136	CbGpPWpGaD
Quazepam—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.000124	0.000124	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000103	0.000103	CbGpPWpGaD
Quazepam—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	8.19e-05	8.19e-05	CbGpPWpGaD
